12.13.22 – Solve M.E. Awarded Grant From Chan Zuckerberg Initiative to Support Patient Engagement in Long Covid Research
08.15.22 – Solve M.E. Launches First Nationwide PSA Campaign to Broaden Awareness of Long Covid
05.12.22 – Solve M.E. Announces Worldwide Launch of Long Haul Voices: Living with Long Covid and ME/CFS in Honor of World ME Day 2022
05.02.22 – Solve M.E Kicks Off Advocacy Month Highlighting Long Covid’s Widespread Impact, Spotlight on ME/CFS
04.14.22 – Responsum Health and Solve M.E. Announce New Partnership
04.05.22 – Solve Long Covid Initiative Launches New Whitepaper, Long Covid’s Impact on Adult Americans: Early Indicators Estimating Prevalence and Cost, Estimating Magnitude of Long Covid Public Health Crisis
“Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome,” mmunoHorizons Read more about Dr. Bhupesh Prusty here.
“Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset,” Frontiers in Immunology
“Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients,” Frontiers in Immunology
“Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model,” Frontiers in Immunology
Accessibility Tools
